You are here

Language:

Frédéric Chevallier

Frédéric Chevallier

Partner

Frédéric Chevallier is a patent law specialist.

Share

Experience

Frédéric is a partner in the firm's IP/TMT practice in Paris specialising in cross-border patent litigation, including the related regulatory aspects in the pharmaceutical field. He has developed particularly strong expertise in the life sciences and TMT fields, having been directly involved in a number of major and high value patent cases since 2010 for leading innovator pharmaceutical companies and leading TMT actors.

Frédéric’s practice focuses on representing pharmaceutical innovators and high-tech companies in cross-border patent litigation involving numerous jurisdictions. He has worked on high-profile cases which notably lead to the CJEU’s first decision addressing the subject matter and effects of a Supplementary Protection Certificate, and confirming the first granted decision in France (even Europe-wide) on this issue. In addition, Frédéric has worked on high-profile, multi-jurisdictional patent dispute involving Standard Essential Patents in the telecommunications field (UMTS and LTE, FRAND).

Frédéric’s experience includes advising:

  • Major international pharmaceutical companies on the enforcement of patent and SPC rights on antibodies, small molecules, and second medical use claims, including in preliminary injunction proceedings.
  • An international company on the remuneration of its employee inventor and assignment of invention.
  • A spray gun manufacturer on the enforcement of its patents.*
  • Major French and foreign smartphone and networks providers on the Pan-European enforcement of their standard essential patents (FRAND).*
  • A major producer of household appliances on the defence of its rights to market washing machines against a third party's patents.*

*prior to joining Herbert Smith Freehills

Background

Prior to joining Herbert Smith Freehills, Frédéric was counsel in the IP department of an international law firm in Paris.

Related news and deals

06 April 2021

Cinq cabinets sur la prise de participation majoritaire de SK Inc. au sein d’Yposkesi